stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Operating cash flow
Clover Health Investments, Corp.'s operating cash flow for fiscal 2025 was −$66.9M, compared with $34.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $135.3M. Over the past ten years it has ranged from −$282.3M (fiscal 2021) to $34.8M (fiscal 2024); the current reading is higher than 86% of that period. Clover Health Investments, Corp. ranks 10th of 12 Healthcare Plans companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$66.9M | — |
| FY2024 | $34.8M | — |
| FY2023 | −$144.7M | — |
| FY2022 | −$203.9M | — |
| FY2021 | −$282.3M | — |
| FY2020 | −$118.5M | — |
| FY2019 | −$159.9M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $70.4M | 179.41% |
| Jun 2026 | $25.2M | (76.66%) |
| Mar 2026 | $107.9M | — |
| Dec 2025 | −$68.2M | — |
| 24 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| CI Cigna Group compare | $9.4B |
| ELV Elevance Health, Inc. compare | $7.6B |
| CNC Centene Corporation compare | $4.7B |
| OSCR Oscar Health, Inc. compare | $4.2B |
| HUM Humana Inc. compare | $3.7B |
| MOH Molina Healthcare, Inc compare | $331.0M |
| PGNY Progyny, Inc. compare | $207.2M |
| CLOV Clover Health Investments, Corp. | $135.3M |
| ALHC Alignment Healthcare, Inc. compare | $108.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement